Literature DB >> 10790735

Multiple sclerosis--in need of a critical reappraisal.

I Steiner1, I Wirguin.   

Abstract

Multiple sclerosis (MS) is a disease that currently defies clinical and scientific definitions. Despite intensive clinical and basic research, very little is known about its possible cause(s) or pathogenesis, and the course and prognosis of MS practically remain unchanged. The aim of the present article is to outline some of the reasons for the constant failure to improve the therapy of MS. It also attempts to offer several guidelines which may enable a fresh and different approach to this devastating condition.

Entities:  

Mesh:

Year:  2000        PMID: 10790735     DOI: 10.1054/mehy.1998.0835

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Quo vadis multiple sclerosis?

Authors:  Israel Steiner; Ronit Mosberg-Galili
Journal:  Inflammopharmacology       Date:  2010-11-03       Impact factor: 4.473

Review 2.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

Review 3.  The conundrum of iron in multiple sclerosis--time for an individualised approach.

Authors:  Susan J van Rensburg; Maritha J Kotze; Ronald van Toorn
Journal:  Metab Brain Dis       Date:  2012-03-17       Impact factor: 3.584

Review 4.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

Review 5.  Infection and the etiology and pathogenesis of multiple sclerosis.

Authors:  I Steiner; P Nisipianu; I Wirguin
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.